1. The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure. (14th October 2021) Authors: Heerspink, J L; Wheeler, D C; Vart, P; Jongs, N; Hou, F F; Langkilde, A M; Correa-Rotter, R; Rossing, P; Sjostrom, C D; Toto, R D; Chertow, G M; Stefansson, B V; McMurray, J J V Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗